Infratil's One-Year Returns Estimated to be Nearly 29% at Mid-August on Back of CDC's Earnings Forecast, CEO Says

MT Newswires Live

Aug 18

Infratil (ASX:IFT, NZE:IFT) one-year returns are estimated to be nearly 29% at mid-August, and its 10-year returns were 20%, reflecting the increase in earnings forecast by CDC Data Centres, Jason Boyes, Infratil's Chief Executive, said, according to a Tuesday Australian bourse filing.

CDC's EBITDAF for the current fiscal year is expected to be between AU$680 million and AU$720 million.

Infratil's CDC shareholding is estimated at 49.7%, and an independent valuation put its share of CDC at over AU$9 billion. The firm remains comfortable with the position and scale of CDC in its portfolio, Boyes added.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2660304452"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2660304452\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2660304452?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-18 14:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2660304452","market":"fut","top_or_hot":-1,"title":"Infratil's One-Year Returns Estimated to be Nearly 29% at Mid-August on Back of CDC's Earnings Forecast, CEO Says","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/IFT.AU\">Infratil</a> (ASX:IFT, NZE:IFT) one-year returns are estimated to be nearly 29% at mid-August, and its 10-year returns were 20%, reflecting the increase in earnings forecast by CDC Data Centres, Jason Boyes, Infratil's Chief Executive, said, according to a Tuesday Australian bourse filing.</p><p>CDC's EBITDAF for the current fiscal year is expected to be between AU$680 million and AU$720 million.</p><p>Infratil's CDC shareholding is estimated at 49.7%, and an independent valuation put its share of CDC at over AU$9 billion. The firm remains comfortable with the position and scale of CDC in its portfolio, Boyes added.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Infratil's One-Year Returns Estimated to be Nearly 29% at Mid-August on Back of CDC's Earnings Forecast, CEO Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInfratil's One-Year Returns Estimated to be Nearly 29% at Mid-August on Back of CDC's Earnings Forecast, CEO Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-08-18 14:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/IFT.AU\">Infratil</a> (ASX:IFT, NZE:IFT) one-year returns are estimated to be nearly 29% at mid-August, and its 10-year returns were 20%, reflecting the increase in earnings forecast by CDC Data Centres, Jason Boyes, Infratil's Chief Executive, said, according to a Tuesday Australian bourse filing.</p><p>CDC's EBITDAF for the current fiscal year is expected to be between AU$680 million and AU$720 million.</p><p>Infratil's CDC shareholding is estimated at 49.7%, and an independent valuation put its share of CDC at over AU$9 billion. The firm remains comfortable with the position and scale of CDC in its portfolio, Boyes added.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CDC","symbol_name":"VictoryShares US EQ Income Enhanced Volatility Wtd ETF","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2660304452","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2660304452","pubTimestamp":1787033648,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Infratil  one-year returns are estimated to be nearly 29% at mid-August, and its 10-year returns were 20%, reflecting the increase in earnings forecast by CDC Data Centres, Jason Boyes, Infratil's Chief Executive, said, according to a Tuesday Australian bourse filing.CDC's EBITDAF for the current fiscal year is expected to be between AU$680 million and AU$720 million.Infratil's CDC shareholding is estimated at 49.7%, and an independent valuation put its share of CDC at over AU$9 billion. The firm remains comfortable with the position and scale of CDC in its portfolio, Boyes added.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"CDC":"VictoryShares US EQ Income Enhanced Volatility Wtd ETF","IFT.NZ":"Infratil Limited Ordinary Shares"},"translate_title":"Infratil 首席执行官表示，根据 CDC 的盈利预测，到 8 月中旬，Infratil 的一年回报率预计接近 29%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CDC":1.5,"IFT.NZ":1.5},"content_text":"Infratil (ASX:IFT, NZE:IFT) one-year returns are estimated to be nearly 29% at mid-August, and its 10-year returns were 20%, reflecting the increase in earnings forecast by CDC Data Centres, Jason Boyes, Infratil's Chief Executive, said, according to a Tuesday Australian bourse filing.CDC's EBITDAF for the current fiscal year is expected to be between AU$680 million and AU$720 million.Infratil's CDC shareholding is estimated at 49.7%, and an independent valuation put its share of CDC at over AU$9 billion. The firm remains comfortable with the position and scale of CDC in its portfolio, Boyes added.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}